Ingestion
[ 2, 3] . Fatal oleander poisonings have been reported in humans [2, 4, 5] , cows [6] , cats [7] , and geese [8] . 1996) , and many incidents of exposure to oleander have been reported in other countries worldwide [2, [9] [10] [11] . Modes of exposure to the plant include accidental ingestions by children [2] as well as intentional administration in foods, drinks, or medicinal preparations prepared from its leaves [5, 10, 12] . Oleander has also been used in suicide attempts [4, 9] , in criminal poisonings, and in rat poison [13] . Symptoms of oleander intoxication are very similar to those of digoxin, in that nausea and vomiting are followed by potentially lethal cardiotoxicity manifested by tachyarrhythmia, bradyarrhythmia, premature ventricular beats, and various types of atrioventricular blocks [14] . Other toxic effects of oleander include burning of the mucous membranes of the eye, mouth, and gastrointestinal tract; bloody diarrhea; xanthopsia (yellow vision); convulsions; respiratory paralysis; and loss of consciousness [2, 15] .
The structural similarity of oleander glycosides to the cardiac glycoside digoxin has led to the use of digoxin-specific Fab fragments ("Digibind"; Glaxo Wellcome, Research Triangle Park, NC) for treatment of oleander poisoning [14, 16, 17] . Oleandrin is one of the major cardiac glycosides present in the common oleander [2, 12, 18] ; similar to digoxin, it contains a steroid nucleus and an unsaturated lactone ring (Fig. 1) . The steroid ring of oleandrin has an additional substitution of an acetyloxy group at C-b and lacks a hydroxyl group at position 12; also, instead of the dideoxy ribose sugars present in digoxin, oleandrin has a dideoxy arabinose. Oleandrigenin, the deglycosylated congener of oleandrin, is not usually included in the list of oleander plant glycosides [2] . This aglycone has been synthesized [19] and has been reported to be present in Adeniurn obesum [20] and Beaumonita brevituba [21] plants.
Liquid chromatographic-mass spectrometric analyses of oleandrin and oleandrigenin in decayed human tissues have been described [22] . Recently, we have also reported on the detection of both of these glycosides by HPLC in the serum of a child
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Clinical Chemistry 42, No. 10, 1996 suspected of exposure to oleander plant.3 Although oleandrin and digoxin have some structural differences, oleander glycosides have been reported to cross-react in digoxin immunoassays [4, 23] . This cross-reactivity has been the basis for recommended screening of suspected oleander poisoning by immunoassays, e.g., RIA [12] .
Here, we have characterized the cross-reactivities of oleandrin and its deglycosylated congener, oleandrigenin, in several commercially available digoxin immunoassays. Using tissue from porcine cerebral cortex, which contains all three ce-isoforms of Na,K-ATPase [24] , we compared the inhibitory potency of oleandrin and oleandrigenin with that of digoxin and ouabain. We also assessed the extent of binding of oleandrin and oleandrigenin to serum proteins. were prepared in digoxin-free serum. Measurement of digoxin-free serum used for cross-reactivity studies gave digoxin concentration of less than the detection limits of all assays except Stratus, which yielded an apparent reading of 0.43 g/L.
Materials and Methods
Materials
The %B/B,, for each assay at a given concentration of cross-reactant was calculated by dividing the assay signal at that concentration by the assay signal for the digoxin-free serum.
Na,K-ATPase catalytic activity inhibition assay. We used the method of Chan and Swaminathan [26] , with several modifications to make the method suitable for very small volumes (so that absorbance could be read with an automated microplate reader). Briefly, 20 tL of sample containing the desired concentration of glycoside was pipetted into a well of a microtiter plate placed in a 37 #{176}C water bath [ concentrator tubes at 4, 25, and 30 #{176}C. For a control, the same additions were made to water. The mixtures were then vortexmixed for 20 s, incubated for 10 mm, and centrifuged at 1800g for 5 h. All parts of experimentation (e.g., incubation and centrifugation)
were performed at the above temperatures. The apparent digoxin concentrations of the samples before ultrafiltration and of the ultrafiltrates after centrifugation were determined by the Roche On-Line assay. We chose to use this assay because it had cross-reactivity to both oleandrin and oleandrigenin.
Results
Cross-reastivily in digoxin immunoassays. Cross-reactivities of oleandrin and oleandrigenin in various digoxin immunoassays are shown in Fig. 2 . The cross-reactivities of oleandrin and oleandrigenin in the ACS and Stratus digoxin assays were negligible. However, these glycosides cross-reacted in the On-Line, TDx, and RIA digoxin assays. To assess possible differences in matrices on the apparent digoxmn measurements presented in Table 1 Because oleandrigenmn has been described as a deglycosylated metabolite of oleandrin [22] , we constructed cross-reactivity curves for both glycosides in several commercially available digoxin immunoassays (Fig. 2) . Although the cross-reactivities of oleandrin and oleandrigenin in the ACS and Stratus digoxin assays were negligible, both glycosides cross-reacted markedly differently in the TDx, On-Line, and RIA digoxin assays. For example, oleandrin was less cross-reactive than oleandrigenin in the On-Line digoxin assay, whereas oleandrigenin was less cross-reactive than oleandrin in the TDx assay. Assuming that the relative concentrations of these two compounds in serum change with time after ingestion, this suggests that measurable apparent digoxin after exposure to oleander may show up in earlier specimens when measured by some digoxin immunoassays (e.g., TDx) and in later specimens when measured by others (e.g., On-Line).
Inhibition of Na,K-
These results point to the importance of selection of appropriate antibodies in preparing reagents for use in digoxmn immunoassays as well as the importance of assay selection according to its intended use (e.g., routine TDM vs emergency screening). For example, because neither oleandrin nor oleandrigenin cross-reacts in the ACS or the Stratus digoxmn assays, one might use such assays along with a cross-reacting assay (e.g., On-Line) to resolve a discrepancy in digoxin results when interference by the presence of oleander is suspected. Inhibition of Na,K-ATPase activity by cardiac glycosides, including digoxin, is known to result in increased intracellular sodium concentrations and subsequently increased calcium. This leads to the positive inotropic effects of these compounds on the heart and potentially to a poisoning of the cells [27] . Although not proved, other toxic manifestations of cardiac glycosides might also be mediated by inhibition of Na,KATPase. Symptoms of oleander intoxication include effects on the gastrointestinal, cardiac, and central nervous system in a manner similar to digoxin [14] . Using commercially available isolates of Na,K-ATPase from porcine cerebral cortex, which contain all three isoforms of the alpha subunit of the enzyme [26] , we evaluated the relative abilities of oleandrin and oleandrigenmn to inhibit the catalytic activity of Na,K-ATPase and compared them with digoxin and ouabain. Oleandrin and its aglycone metabolite had IC50 values greater than that of ouabain but less than that of digoxin (Fig. 3) . These results are in agreement with cellular toxicity studies of human HeLa cells by cardiac glycosides, in which oleandrin was shown to be more cytotoxic than digoxin [28] .
The 
